BASF licenses CRISPR-Cas9 genome-editing technology from the Broad Institute
In North Carolina, BASF reached a global licensing agreement with the Broad Institute of MIT and Harvard for the use of CRISPR-Cas9 genome-editing technology to improve products in agricultural and industrial microbiology applications. The technology advances genome editing because it has the potential to be a simpler and more precise tool for making targeted changes […]











